000 | 02002 a2200577 4500 | ||
---|---|---|---|
005 | 20250515103621.0 | ||
264 | 0 | _c20080403 | |
008 | 200804s 0 0 eng d | ||
022 | _a1521-0111 | ||
024 | 7 |
_a10.1124/mol.107.042911 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMoncunill, Gemma | |
245 | 0 | 0 |
_aAnti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026. _h[electronic resource] |
260 |
_bMolecular pharmacology _cApr 2008 |
||
300 |
_a1264-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xchemistry |
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 | _aBenzylamines |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aChemokine CXCL12 _xpharmacology |
650 | 0 | 4 |
_aChemotaxis _xdrug effects |
650 | 0 | 4 | _aCyclams |
650 | 0 | 4 |
_aDrug Resistance, Viral _xdrug effects |
650 | 0 | 4 |
_aHIV _xdrug effects |
650 | 0 | 4 |
_aHeterocyclic Compounds _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
650 | 0 | 4 |
_aLymphoid Tissue _xdrug effects |
650 | 0 | 4 |
_aMacrophages _xdrug effects |
650 | 0 | 4 |
_aPeptides, Cyclic _xchemistry |
650 | 0 | 4 |
_aReceptors, CXCR4 _xantagonists & inhibitors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aViral Envelope Proteins _xmetabolism |
650 | 0 | 4 |
_aVirus Replication _xdrug effects |
700 | 1 | _aArmand-Ugón, Mercedes | |
700 | 1 | _aClotet-Codina, Imma | |
700 | 1 | _aPauls, Eduardo | |
700 | 1 | _aBallana, Ester | |
700 | 1 | _aLlano, Anuska | |
700 | 1 | _aRomagnoli, Barbara | |
700 | 1 | _aVrijbloed, Jan W | |
700 | 1 | _aGombert, Frank O | |
700 | 1 | _aClotet, Bonaventura | |
700 | 1 | _aDe Marco, Steve | |
700 | 1 | _aEsté, José A | |
773 | 0 |
_tMolecular pharmacology _gvol. 73 _gno. 4 _gp. 1264-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.107.042911 _zAvailable from publisher's website |
999 |
_c17692335 _d17692335 |